Related Experiment Videos

ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a

Maximilian Filzmayer1,2, Michele Petix3,4,5, Leonardo Quarta3,6,7

  • 1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. filzmayer@med.uni-frankfurt.de.

Abstract

No abstract available in PubMed .